Literature DB >> 21336883

[Epidemiology of chronic non-malignant pain in Germany].

R Wolff1, C Clar, C Lerch, J Kleijnen.   

Abstract

BACKGROUND: Although chronic pain is a common health problem, epidemiological data are rare. The aim of this study is to present information on chronic, non-malignant pain in Germany.
METHODS: In order to identify relevant studies on chronic pain (> 3 months) a total of 7 databases were searched in the timeframe from 1995 to 2009. Representative, recent, comprehensive and valid studies were selected.
RESULTS: The prevalence of chronic pain in Germany is estimated to be 17% and varies according to the underlying cause of the disease. Neck, shoulder and back pain are the most common forms. Chronic pain has a direct impact on quality of life (QoL), days off work and costs. A variety of drugs and non-drug treatments are used. However, treatment is often inadequate with 13-51% of the patients receiving insufficient pain therapy.
CONCLUSIONS: Chronic pain is a common problem which influences the QoL of patients resulting in high costs for the health system. Treatment is often inadequate. More research is needed to close knowledge gaps. The transfer of research results into clinical practice should be improved.

Entities:  

Mesh:

Year:  2011        PMID: 21336883     DOI: 10.1007/s00482-010-1011-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  38 in total

1.  [Distribution of pain parameters for chronic pain patients in comparison to the general population].

Authors:  F L Komarahadi; H Baumeister; C Maurischat; M Härter
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

2.  Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT).

Authors:  Rainer Freynhagen; Ralf Baron; Thomas Tölle; Edgar Stemmler; Ulrich Gockel; Markus Stevens; Christoph Maier
Journal:  Curr Med Res Opin       Date:  2006-03       Impact factor: 2.580

3.  [Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups].

Authors:  H Neuhauser; U Ellert; T Ziese
Journal:  Gesundheitswesen       Date:  2005-10

4.  [Prevalence and risk factors of phantom limb pain and phantom limb sensations in Germany. A nationwide field survey].

Authors:  U Kern; V Busch; M Rockland; M Kohl; F Birklein
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

5.  [Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation].

Authors:  W Häuser; N Grulke; D Michalski; A Hoffmann; I Akritidou; S Klauenberg; C Maier; A Hinz
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

6.  Clinical and economic characteristics of patients with painful neuropathic disorders in Germany.

Authors:  Ariel Berger; Thomas Toelle; Alesia Sadosky; Ellen Dukes; John Edelsberg; Gerry Oster
Journal:  Pain Pract       Date:  2008-10-08       Impact factor: 3.183

7.  [Prevalence and predictors of pain in several body regions. Results of a representative German population survey].

Authors:  W Häuser; G Schmutzer; H Glaesmer; E Brähler
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

8.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

9.  [Health-related quality of life in patients with chronic pain].

Authors:  H U Gerbershagen; G Lindena; J Korb; S Kramer
Journal:  Schmerz       Date:  2002-08       Impact factor: 1.107

10.  [Therapy of patients with chronic back pain. Prescriptions--contentment--outcome].

Authors:  E-K Renker; J Schlüter; E Neubauer; M Schiltenwolf
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

View more
  26 in total

1.  [Multimodal pain therapy: An established procedure?].

Authors:  R Sabatowski; U Kaiser
Journal:  Schmerz       Date:  2012-12       Impact factor: 1.107

Review 2.  [Specialized pain care in Germany].

Authors:  M Dietl; D Korczak
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

3.  [Chronic pain care : Reality and entitlement].

Authors:  K Kieselbach; M Schiltenwolf; C Bozzaro
Journal:  Schmerz       Date:  2016-08       Impact factor: 1.107

4.  [Just one number alone will not suffice: For a differentiating epidemiological collation of chronic pain].

Authors:  F Petzke; T Kohlmann
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

5.  [Conversion to tapentadol PR improves analgesia and quality of life in patients with severe and chronic pain despite using tramadol > 300 mg/d].

Authors:  Uwe Richter; Susanne Waldmann-Rex; Ute Lehmann
Journal:  Wien Klin Wochenschr       Date:  2014-11-20       Impact factor: 1.704

6.  [Prevalence of disabling abdominal pain and menstrual cramp. Results from a representative survey of the general German population].

Authors:  W Häuser; G Schmutzer; E Brähler
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

Review 7.  Efficacy of Biofeedback in Chronic back Pain: a Meta-Analysis.

Authors:  Robert Sielski; Winfried Rief; Julia Anna Glombiewski
Journal:  Int J Behav Med       Date:  2017-02

8.  [Prevalence of chronic pain in Germany. A representative survey of the general population].

Authors:  W Häuser; G Schmutzer; A Hinz; A Hilbert; E Brähler
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

9.  [Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].

Authors:  W Häuser; U Marschall; H L'hoest; K Komossa; P Henningsen
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

10.  [Manual trigger point therapy of shoulder pain : Randomized controlled study of effectiveness].

Authors:  S Sohns; K Schnieder; G Licht; H von Piekartz
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.